A Study to Provide Complementary Efficacy, Safety and Patient Reported Outcomes Data in Participants With Active Relapsing Forms of Multiple Sclerosis (MS) in a Pragmatic Setting

PHASE4CompletedINTERVENTIONAL
Enrollment

423

Participants

Timeline

Start Date

August 6, 2018

Primary Completion Date

February 15, 2021

Study Completion Date

February 15, 2021

Conditions
Multiple Sclerosis
Interventions
DRUG

Ocrelizumab 300 mg

Two doses of 300 mg infusion administered 14 days apart.

DRUG

Ocrelizumab 600 mg

A single does of 600 mg infusion administered 24 weeks after the initial dose.

Trial Locations (46)

13003

Hopital européen de Marseille; Neurologie, Marseille

13005

CHU de la Timone - Hopital d Adultes; Service de Neurologie, Marseille

13285

Fondation Hopital Saint Joseph; Neurologie, Marseille

14033

Hopital Cote De Nacre; Unite Neurologie Generale, Caen

21079

Hôpital General - Service de neurologie; Service de neurologie, Dijon

25030

CHU de Besancon Hopital Jean Minjoz; Service de Neurologie, Besançon

26953

Centre hospitalier de Valence; Neurologie, Valence

29000

Centre Hospitalier de Cornouaille; Neurologie, Quimper

29609

CHU Brest Hopital La Cavale Blanche; Neurologie, Brest

30900

CHU de Nîmes Hopital Caremeau; Service de Neurologie, Nîmes

33076

Groupe Hospitalier Pellegrin; Service de neurochirurgie B, Bordeaux

33505

Centre hospitalier de Libourne Hopital Robert Boulin; Neurologie, Libourne

34295

Hopital Gui de Chauliac; Neurologie, Montpellier

35033

Hopital Pontchaillou, Rennes

38700

CHU de Grenoble; Neurologie, La Tronche

42270

CHU Saint Etienne - Hôpital Nord; Neurologie, Saint-Priest-en-Jarez

44805

Hôpital Guillaume et René Laënnec; Service Neurologie, Nantes

46005

CH Jean Rougier; Neurologie, Cahors

47923

Centre hospitalier d'Agen; Neurologie, Agen

49933

CHU Angers, Batiement Larrey 2, Neurologie, Angers

54035

Hopital Central - CHU de Nancy; Service de Neurologie, Nancy

59000

CH St Vincent de Paul, Lille

59208

Centre hospitalier Guy Chatiliez de Tourcoing; Neurologie, Tourcoing

62107

Ch De Calais; Hopital De Jour, Calais

63003

CHU Hopital Gabriel Montpied; Service de Neurologie, Clermont-Ferrand

67091

Hopital Civil de Strasbourg; Service de Neurologie, Strasbourg

68070

Centre hospitalier de Mulhouse Hopital Emile Muller; Neurologie, Mulhouse

69677

Hopital Pierre Wertheimer; Neurologie D, Bron

72037

CH Le Mans; Neurologie, Le Mans

73011

CHMS Site Chambery; Neurologie, Chambéry

74370

Centre hospitalier Annecy Genevois Site St Julien; Neurologie, Metz-Tessy

75014

Groupe Hospitalier Paris Saint Joseph; Service de Neurologie et Neurovasculaire, Paris

75019

Fondation Rothschild; Service de Neurologie, Paris

75571

Hopital Saint Antoine; Neurologie, Paris

76031

Hôpital Charles Nicolle; Service de Neurologie, Rouen

77104

Gh De Meaux; Neurologie, Meaux

78157

Centre hospitalier Andre Mignot; Neurologie, Le Chesnay

80054

CHU Amiens Hopital Sud; Neurologie, Amiens Cedex1

83041

HIA de Toulon hôpital militaire; Neurologie, Toulon

86021

CHU Poitiers - La Milétrie; Neurologie, Poitiers

87042

CHU Dupruytren - Limoges; Neurologie, Limoges

92151

Hopital Foch; Neurologie, Suresnes

95503

CH de Gonesse; Neurologie, Gonesse

Unknown

Hopital Roger Salengro; Service de Neurologie, Lille

03100

Centre hospitalier de Montlucon; Neurologie, Montluçon

06002

Hôpital Pasteur; Service de Neurologie, Nice

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT03589105 - A Study to Provide Complementary Efficacy, Safety and Patient Reported Outcomes Data in Participants With Active Relapsing Forms of Multiple Sclerosis (MS) in a Pragmatic Setting | Biotech Hunter | Biotech Hunter